Published in Neuroscience on January 01, 1991
Dopamine in motivational control: rewarding, aversive, and alerting. Neuron (2010) 6.26
Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse. Schizophr Res (2011) 5.39
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology (Berl) (2006) 4.43
Cortico-Basal Ganglia reward network: microcircuitry. Neuropsychopharmacology (2010) 3.81
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A (2000) 3.34
Affective neuroscience of pleasure: reward in humans and animals. Psychopharmacology (Berl) (2008) 3.26
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nat Rev Neurosci (2010) 3.05
Disrupted prediction-error signal in psychosis: evidence for an associative account of delusions. Brain (2007) 2.77
Linking nucleus accumbens dopamine and blood oxygenation. Psychopharmacology (Berl) (2007) 2.65
Opponency revisited: competition and cooperation between dopamine and serotonin. Neuropsychopharmacology (2010) 2.34
Understanding dopamine and reinforcement learning: the dopamine reward prediction error hypothesis. Proc Natl Acad Sci U S A (2011) 2.33
Do patients with schizophrenia exhibit aberrant salience? Psychol Med (2008) 2.28
The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia. Stereotact Funct Neurosurg (2009) 2.24
Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur J Neurosci (2009) 2.11
Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci U S A (1993) 2.08
Kynurenine pathway metabolites in humans: disease and healthy States. Int J Tryptophan Res (2009) 2.01
Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior. Science (2016) 2.00
Serotonin and dopamine: unifying affective, activational, and decision functions. Neuropsychopharmacology (2010) 1.87
The Yin and Yang of dopamine release: a new perspective. Neuropharmacology (2007) 1.85
The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc Natl Acad Sci U S A (2006) 1.85
Reward, addiction, withdrawal to nicotine. Annu Rev Neurosci (2011) 1.83
Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci (2010) 1.82
Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis. Neuropsychopharmacology (2011) 1.78
Genetic variation in dopaminergic neuromodulation influences the ability to rapidly and flexibly adapt decisions. Proc Natl Acad Sci U S A (2009) 1.76
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord (2012) 1.73
Toward a neurobiology of delusions. Prog Neurobiol (2010) 1.70
Molecular and cellular basis of small--and intermediate-conductance, calcium-activated potassium channel function in the brain. Cell Mol Life Sci (2008) 1.67
A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote reward. Neuron (2013) 1.66
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness. Psychopharmacology (Berl) (2007) 1.64
Escalated or suppressed cocaine reward, tegmental BDNF, and accumbal dopamine caused by episodic versus continuous social stress in rats. J Neurosci (2011) 1.62
From drugs to deprivation: a Bayesian framework for understanding models of psychosis. Psychopharmacology (Berl) (2009) 1.60
Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia. Behav Brain Res (2009) 1.60
Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull (2008) 1.59
Altered Excitatory-Inhibitory Balance in the NMDA-Hypofunction Model of Schizophrenia. Front Mol Neurosci (2008) 1.58
Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum. Mol Pharmacol (2009) 1.56
Increased phasic dopamine signaling in the mesolimbic pathway during social defeat in rats. Neuroscience (2009) 1.52
The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl) (2003) 1.49
Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology (Berl) (2004) 1.48
Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct (2005) 1.47
Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse. Curr Top Behav Neurosci (2010) 1.46
Developmental changes in dopamine neurotransmission in adolescence: behavioral implications and issues in assessment. Brain Cogn (2009) 1.44
Dopamine modulation in the basal ganglia locks the gate to working memory. J Comput Neurosci (2006) 1.44
Distinct tonic and phasic anticipatory activity in lateral habenula and dopamine neurons. Neuron (2010) 1.44
Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain Behav Immun (2008) 1.42
Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: a mechanism of behavioral sensitization. J Neurosci (2008) 1.39
Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats. Neuropsychopharmacology (2010) 1.39
Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain (2008) 1.37
Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum. J Neurosci (2006) 1.35
Rapid dopamine dynamics in the accumbens core and shell: learning and action. Front Biosci (Elite Ed) (2013) 1.34
Glutamatergic model psychoses: prediction error, learning, and inference. Neuropsychopharmacology (2010) 1.34
Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci U S A (1994) 1.30
The dopaminergic basis of human behaviors: A review of molecular imaging studies. Neurosci Biobehav Rev (2009) 1.30
Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology (2007) 1.30
Action controls dopaminergic enhancement of reward representations. Proc Natl Acad Sci U S A (2012) 1.29
Modulators in concert for cognition: modulator interactions in the prefrontal cortex. Prog Neurobiol (2007) 1.28
A dynamic role for GABA receptors on the firing pattern of midbrain dopaminergic neurons. J Neurophysiol (2010) 1.27
Cav1.3 channel voltage dependence, not Ca2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons. J Neurosci (2009) 1.27
Deficiency of Aph1B/C-gamma-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment. Proc Natl Acad Sci U S A (2008) 1.26
Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J Neurosci (2010) 1.24
Metabolic hormones, dopamine circuits, and feeding. Front Neuroendocrinol (2009) 1.22
rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One (2009) 1.22
Dopamine modulates reward-related vigor. Neuropsychopharmacology (2013) 1.22
Schizophrenia, myelination, and delayed corollary discharges: a hypothesis. Schizophr Bull (2010) 1.21
Social 'wanting' dysfunction in autism: neurobiological underpinnings and treatment implications. J Neurodev Disord (2012) 1.21
In search of the neural circuits of intrinsic motivation. Front Neurosci (2007) 1.19
Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia. J Neurosci (2011) 1.18
Dopamine modulates persistent synaptic activity and enhances the signal-to-noise ratio in the prefrontal cortex. PLoS One (2009) 1.17
Positive affect versus reward: emotional and motivational influences on cognitive control. Front Psychol (2011) 1.16
Rapid microelectrode measurements and the origin and regulation of extracellular glutamate in rat prefrontal cortex. J Neurochem (2010) 1.15
Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module. Brain Res Rev (2007) 1.14
Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol (2015) 1.14
Convergent evidence for abnormal striatal synaptic plasticity in dystonia. Neurobiol Dis (2009) 1.13
Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A (1998) 1.11
The effects of background white noise on memory performance in inattentive school children. Behav Brain Funct (2010) 1.11
Differential effects of COMT on gait and executive control in aging. Neurobiol Aging (2008) 1.10
Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction. Pain (2012) 1.09
Phasic mesolimbic dopamine release tracks reward seeking during expression of Pavlovian-to-instrumental transfer. Biol Psychiatry (2013) 1.08
The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism. Sleep Med Rev (2012) 1.07
Tonic autoinhibition contributes to the heterogeneity of evoked dopamine release in the rat striatum. J Neurochem (2009) 1.07
Probabilistic reversal learning is impaired in Parkinson's disease. Neuroscience (2009) 1.06
Stress responses and the mesolimbic dopamine system: social contexts and sex differences. Horm Behav (2011) 1.06
Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress. Neurotox Res (2010) 1.05
Influence of SLC6A3 and COMT variation on neural activation during response inhibition. Biol Psychol (2009) 1.04
Structural neuroimaging of the basal ganglia in schizophrenic patients: a review. Wien Med Wochenschr (2008) 1.04
Dual roles of dopamine in food and drug seeking: the drive-reward paradox. Biol Psychiatry (2012) 1.03
Dopamine D1/D5 receptors mediate informational saliency that promotes persistent hippocampal long-term plasticity. Cereb Cortex (2012) 1.02
Increased intrinsic brain activity in the striatum reflects symptom dimensions in schizophrenia. Schizophr Bull (2012) 1.02
Tuning the excitability of midbrain dopamine neurons by modulating the Ca2+ sensitivity of SK channels. Eur J Neurosci (2009) 1.02
Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat. Psychopharmacology (Berl) (2008) 1.02
Mapping anhedonia onto reinforcement learning: a behavioural meta-analysis. Biol Mood Anxiety Disord (2013) 1.02
Dopamine and baclofen inhibit the hyperpolarization-activated cation current in rat ventral tegmental neurones. J Physiol (1993) 1.01
Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berl) (2009) 1.01
Dopamine reward prediction-error signalling: a two-component response. Nat Rev Neurosci (2016) 1.01
A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harb Perspect Med (2012) 1.00
Reinforcement learning and dopamine in schizophrenia: dimensions of symptoms or specific features of a disease group? Front Psychiatry (2013) 1.00
Alpha-2 noradrenergic receptor activation inhibits the hyperpolarization-activated cation current (Ih) in neurons of the ventral tegmental area. Neuroscience (2010) 0.99
Assessing rod, cone, and melanopsin contributions to human pupil flicker responses. Invest Ophthalmol Vis Sci (2014) 0.99
Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia. Neurotox Res (2008) 0.99
Spatiotemporal specificity in cholinergic control of neocortical function. Curr Opin Neurobiol (2014) 0.98